Pharmaceutical giant Merck & Co. has agreed to pay $100 million to settle the NuvaRing litigation, rather than face thousands of individual lawsuits brought on behalf of women who allege that they experienced 
severe blood clot injuries associated with the NuvaRing birth control device. During a February 7th hearing before New Jersey Superior Judge Brian R. Martinotti, a settlement agreement was announced that would resolve all NuvaRing birth control lawsuits pending in federal and state courts, in addition to qualifying cases yet to be filed. If you believe you have been adversely affected by side effects of NuvaRing or another potentially dangerous medical device, our consumer advocates at the Consumer Justice Foundation can help. We can put you in touch with a skilled lawyer who has experience handling product liability cases.
Although Merck promoted its NuvaRing birth control device as carrying risks similar to oral contraceptives, studies have suggested that women using the NuvaRing may actually face a considerably higher risk of blood clots than women using oral birth control pills. Plaintiffs involved in the NuvaRing litigation claim that, had Merck provided accurate information about the potential risk of NuvaRing blood clot side effects, they may have avoided serious injury by choosing an alternative method of pregnancy prevention. If you or a loved one has suffered serious blood clot injuries while using Merck’s NuvaRing product, you may be entitled to financial compensation for your injuries and associated medical expenses. Contact an experienced NuvaRing attorney today for legal help.
